These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 15009821)
1. Open label study of the effect of amantadine on weight gain induced by olanzapine. Bahk WM; Lee KU; Chae JH; Pae CU; Jun T; Kim KS Psychiatry Clin Neurosci; 2004 Apr; 58(2):163-7. PubMed ID: 15009821 [TBL] [Abstract][Full Text] [Related]
2. Amantadine for weight gain associated with olanzapine treatment. Deberdt W; Winokur A; Cavazzoni PA; Trzaskoma QN; Carlson CD; Bymaster FP; Wiener K; Floris M; Breier A Eur Neuropsychopharmacol; 2005 Jan; 15(1):13-21. PubMed ID: 15572269 [TBL] [Abstract][Full Text] [Related]
3. Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study. Hoffmann VP; Case M; Jacobson JG J Clin Psychiatry; 2012 Feb; 73(2):216-23. PubMed ID: 21672497 [TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine. Graham KA; Gu H; Lieberman JA; Harp JB; Perkins DO Am J Psychiatry; 2005 Sep; 162(9):1744-6. PubMed ID: 16135638 [TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine. Ball MP; Warren KR; Feldman S; McMahon RP; Kelly DL; Buchanan RW Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):17-25. PubMed ID: 21459735 [TBL] [Abstract][Full Text] [Related]
6. A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder. Detke HC; DelBello MP; Landry J; Hoffmann VP; Heinloth A; Dittmann RW J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):922-934. PubMed ID: 27676420 [TBL] [Abstract][Full Text] [Related]
7. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial. Baptista T; Rangel N; Fernández V; Carrizo E; El Fakih Y; Uzcátegui E; Galeazzi T; Gutiérrez MA; Servigna M; Dávila A; Uzcátegui M; Serrano A; Connell L; Beaulieu S; de Baptista EA Schizophr Res; 2007 Jul; 93(1-3):99-108. PubMed ID: 17490862 [TBL] [Abstract][Full Text] [Related]
8. Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia. Kemp DE; Correll CU; Tohen M; Delbello MP; Ganocy SJ; Findling RL; Chang K J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):522-30. PubMed ID: 24111982 [TBL] [Abstract][Full Text] [Related]
9. Weight gain during treatment of bipolar I patients with olanzapine. Hennen J; Perlis RH; Sachs G; Tohen M; Baldessarini RJ J Clin Psychiatry; 2004 Dec; 65(12):1679-87. PubMed ID: 15641874 [TBL] [Abstract][Full Text] [Related]
10. Effect of amantadine on weight gain during olanzapine treatment. Floris M; Lejeune J; Deberdt W Eur Neuropsychopharmacol; 2001 Apr; 11(2):181-2. PubMed ID: 11313165 [TBL] [Abstract][Full Text] [Related]
11. The antidepressant effects of risperidone and olanzapine in bipolar disorder. McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475 [TBL] [Abstract][Full Text] [Related]
12. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. Kwon JS; Choi JS; Bahk WM; Yoon Kim C; Hyung Kim C; Chul Shin Y; Park BJ; Geun Oh C J Clin Psychiatry; 2006 Apr; 67(4):547-53. PubMed ID: 16669719 [TBL] [Abstract][Full Text] [Related]
13. Olanzapine: in adolescents with schizophrenia or bipolar I disorder. McCormack PL CNS Drugs; 2010 May; 24(5):443-52. PubMed ID: 20369908 [TBL] [Abstract][Full Text] [Related]
14. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179 [TBL] [Abstract][Full Text] [Related]
15. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327 [TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia. Chan HY; Chiang SC; Chang CJ; Gau SS; Chen JJ; Chen CH; Hwu HG; Lai MS J Clin Psychiatry; 2010 Sep; 71(9):1226-33. PubMed ID: 20441726 [TBL] [Abstract][Full Text] [Related]
17. An open-label trial of olanzapine for corticosteroid-induced mood symptoms. Brown ES; Chamberlain W; Dhanani N; Paranjpe P; Carmody TJ; Sargeant M J Affect Disord; 2004 Dec; 83(2-3):277-81. PubMed ID: 15555725 [TBL] [Abstract][Full Text] [Related]
18. Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. Mostafavi SA; Solhi M; Mohammadi MR; Akhondzadeh S J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):440-444. PubMed ID: 28339282 [TBL] [Abstract][Full Text] [Related]
19. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. Kryzhanovskaya L; Schulz SC; McDougle C; Frazier J; Dittmann R; Robertson-Plouch C; Bauer T; Xu W; Wang W; Carlson J; Tohen M J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413 [TBL] [Abstract][Full Text] [Related]